Cargando…
Inhibition of HIV-1 replication using the CRISPR/cas9-no NLS system as a prophylactic strategy
Globally, it is estimated that 43 million people are living with human immunodeficiency virus type 1 (HIV-1), and there are more than 600,000 acquired immunodeficiency syndrome (AIDS)-related deaths in 2020. The only way to increase the life expectancy of these patients right now is to use combinati...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489754/ https://www.ncbi.nlm.nih.gov/pubmed/36158108 http://dx.doi.org/10.1016/j.heliyon.2022.e10483 |